A r t i c l e s shown to cause NPHP-RC [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . The discovery that proteins that are mutated in cystic kidney diseases are located at the primary ciliumcentrosome complex provided a unifying disease mechanism for NPHP-RC, characterizing them as ciliopathies. Many of the NPHP-RC gene products interact at the cilium-centrosome complex throughout the cell cycle. In more than 70% of cases of NPHP-RC, the causative gene is unknown 12 . Furthermore, in families with severe forms of NPHP-RC, we did not detect a mutation in any of the nine known NPHP-RC-causing genes in 90 of 120 families (75%) (our unpublished data). Upon homozygosity mapping, 50 of these families showed putative homozygous disease loci, of which more than 30 showed no positional overlap, strongly indicating that many additional recessive NPHP-RC genes must exist.
RESULTS

Combining homozygosity mapping with exome capture
The finding that most known NPHP-RC genes caused the disorder only in a small number of cases (<1%) 9 necessitated the ability to map and identify disease genes in single families. We therefore developed a strategy that combines homozygosity mapping in single families 13 with exon capture and consecutive massively parallel sequencing 14 . Using the NimbleGen 385K platform, we designed a ciliopathy candidate exon capture array, which contains oligonucleotides that interrogate ~13,000 exons from the 'UCSC Gene' annotation (see URLs) of 828 NPHP-RC candidate genes. Candidate genes were derived from ciliopathy animal models, from the photoreceptor sensory cilia proteome 15 and from other candidate sources 16 (Supplementary Tables 1-3) .
Because exon capture with subsequent massively parallel sequencing yields too many variants from normal reference sequence (VRSs) to make a safe call regarding the disease-causing mutation 14 , we devised a strategy of a priori reduction of VRSs ( Supplementary  Table 1 ). These a priori restriction criteria consisted of: (i) capturing only ~13,000 ciliopathy candidate exons instead of all ~180,000 exons from the collaborative consensus coding sequence (CCDS) project (~15-fold reduction; Supplementary Table 1 ); (ii) evaluating coding SNPs, splice variants and indels only (as other variants will be difficult to interpret); (iii) removing VRSs from a database of innocuous SNPs (dbSNP130; 2.3-fold reduction); (iv) evaluating only within the mapped homozygous candidate region of an individual or family (~20-fold reduction); and (v) preferentially evaluating truncating mutations (~4-fold reduction). This approach allowed us to reduce the number of VRSs by an average of ~2,760-fold and led to the identification of the disease-causing gene in 3 out of 5 attempts ( Supplementary Table 1 ). We discovered homozygous mutations in the known NPHP-RC genes AHI1 (family A2045) and INVS (family A128; Supplementary Table 1 ). More importantly, we discovered a homozygous mutation in SDCCAG8 as a new cause of NPHP-RC (Supplementary Table 1 ).
Null mutations of SDCCAG8 cause retinal-renal degeneration
In consanguineous family SS23/A1365, two siblings had Senior-Loken syndrome (SLSN), in which nephronophthisis is associated with retinal degeneration. Homozygosity mapping using the Affymetrix 250K StyI SNP platform yielded four segments of homozygosity 13 (Fig. 1a) . Because none of the four homozygous segments (red circles in Fig. 1a ) coincided with any of the nine known loci for NPHP-RC (dashed lines in Fig. 1a ), we hypothesized that SLSN in family SS23/A1365 must be caused by a recessive mutation in a new NPHP-RC-causing gene. Exon capture and massively parallel sequencing ( Fig. 1b) led to the identification of a homozygous truncation mutation (p.E474fsX493) in SDCCAG8 (Fig. 1c-f and Table 1 ).
When investigating 11 families with NPHP-RC in whom we had shown homozygosity at the SDCCAG8 locus 13 , we detected four additional homozygous mutations ( Fig. 1f ; primer sequences for SDCCAG8 sequence analysis are provided in Supplementary Table 2 ). These were ( Fig. 1f and Table 1 ): (i) a deletion of exons 5-7 in F159; (ii) an obligatory splice site mutation (c.1068+1G>A) in A2290; (iii) a homozygous 1-bp insertion (resulting in p.Glu447fsX463) in SS-F336; and (iv) a homozygous nonsense mutation (p.Leu599X) in F1054. Direct exon sequencing of 118 families with SLSN yielded a 4-bp deletion resulting in a reading frame shift of the deduced amino acid sequence (p.Cys649fsX658) in F195 ( Fig. 1f and Table 1 ). No mutations were detected by direct exon sequencing in 54 families with Joubert syndrome who had renal involvement with NPHP. All mutations were absent from >270 healthy control individuals and from healthy controls of the 1,000 Genomes Project (see URLs) ( Table 1) .
We also carried out an independent homozygosity mapping study (using the Affymetrix 6.0 SNP) on 22 consanguineous families diagnosed with Bardet-Biedl syndrome (BBS) for which no mutation was detected on genomic sequencing of 12 known BBS genes. For one large family (FI.2), we identified a unique segment of homozygosity on chromosome 1 (240-242.38 Mb) encompassing five genes (PLD5, CEP170, SDCCAG8, AKT3 and ZNF238), for which sequencing of all coding exons was normal. Subsequently, we performed RT-PCR with overlapping primer sets for the five genes on RNA from fibroblast cell lines derived from the four affected family members. Abnormal fragments were obtained when amplifying exons 7 and 8 of SDCCAG8 (Supplementary Fig. 1a,b) . Sequencing of the products revealed various complex aberrant intron 7 insertions with a homozygous deep intronic mutation (c.740+356c>t) predicted to cause loss of an exonic splice enhancer site, with the result of aberrant splicing introducing an in-frame stop codon 17 (Supplementary Fig. 1c-e ). This mutation leads to almost complete absence of the full-length SDCCAG8 product as confirmed by RT-PCR and immunoblotting ( Supplementary  Fig. 1f-h) . The finding that some residual full-length splice product and protein product remains ( Supplementary Fig. 1a ,b,f-h) may explain the relatively late onset of renal failure and retinal degeneration in this kindred ( Table 1) . Quantitative PCR analysis performed with primers bordering exons 8 and 9 amplified a significantly lower level of RNA compared with the control (Supplementary Fig. 1g,h) , and protein blot confirmed trace amounts of protein (data not shown). The mutation was absent from >270 healthy control individuals and segregated with the disease in the family.
In the same study, another consanguineous family (FII.22) with two siblings diagnosed with BBS (on the basis of obesity and mild mental retardation) showed overlapping homozygosity for the same chromosome 1 region. Exon sequencing of SDCCAG8 revealed a homozygous nonsense mutation (p.Lys227X). Because of these data, we initiated an unbiased (with regard to mutations at other loci) sequencing of SDCCAG8 in 96 unrelated individuals with BBS and found two families in which compound heterozygous loss-of-function mutations seemed to be sufficient to cause the disorder. Family NK-F1063 carried two deletions causing frame shifts (p.Thr482fsX493 and p.Asp543fsX566), whereas in AR37, we found a nonsense allele and a splice site mutation (p.Tyr232X and IVS7+1delG) ( Table 1) . Both families had some of the six primary features of BBS (retinal degeneration, postaxial polydactyly, truncal obesity, learning disabilities, hypogonadism and renal anomalies) 18 . However, none of the affected individuals had polydactyly ( Table 1) . We also detected two unique heterozygous alleles in two additional families: a p.Glu520Gly change in Northern European family AR605 and a p.Glu531Lys change in A r t i c l e s Middle Eastern family KK11 (data not shown). We did not identify any SDCCAG8 mutations in 40 other BBS families who did not carry a known BBS gene mutation. Likewise, we detected no mutations in SDCCAG8 upon direct exon sequencing of 90 unrelated families with isolated juvenile-onset retinitis pigmentosa.
All individuals from 10 families with 12 different homozygous or compound heterozygous truncating mutations in SDCCAG8 had nephronophthisis and retinal degeneration (SLSN; Table 1 ). Some had in addition mild mental retardation, and two had signs of BBS (obesity and hypogenitalism) 19 . We thus identified recessive mutations of A r t i c l e s SDCCAG8 as a new cause of SLSN with some additional BBS-related features. All ten families had two truncating mutations and showed a degenerative phenotype of kidney and eye. Recessive mutations in SDCCAG8 explain 3.3% (6/182) of cases in our worldwide SLSN cohort. To indicate the phenotypic relationship between SDCCAG8 loss of function and other NPHP-RC loci, we have assigned the protein the aliases 'SLSN7' and 'NPHP10' . SDCCAG8 spans 244 kb at chromosome 1q44 ( Fig. 1c) . Up to 22 different putative alternatively spliced SDCCAG8 transcripts encoding different proteins have been proposed (see URLs). To identify the relevant transcripts, we designed primers complementary to the different potential splice variants and confirmed by sequencing the existence of three SDCCAG8 isoforms in cells from the human retinal cell line hTERT-RPE1. The full-length cDNA of SDCCAG8 (isoform a; NM_006642) encodes an 82.7-kDa protein (713 amino acids; Fig. 1d ). Isoform b lacks exon 6 compared to isoform a, and isoform e is C-terminally truncated beyond exon 9 ( Supplementary Fig. 2i ). RNA blot analysis had described a single 3.3-kb band expressed at low levels in mouse liver, spleen, kidney, brain, heart and muscle, consistent with the full-length (isoform-a) of 3,267 nucleotides 20 . The fulllength cDNA of SDCCAG8 encodes an 82.7-kDa protein (713 amino acids) ( Fig. 1e) . RNA blot data and the observation that homozygous truncating mutations are found in most exons of full-length isoform a ( Fig. 1d-f ) support the notion that this full-length isoform is the relevant one for the retinal-renal phenotype of this disease.
Analysis of the deduced amino acid sequence of SDCCAG8 yielded an N-terminal globular domain, a nuclear localization signal and eight putative coiled-coil domains 20 (Fig. 1e) . Coiled-coil domains are a feature shared by most proteins that are disrupted in NPHP-RC. Nuclear localization signals are also found in CEP290 and INVS 21 . In addition to being part of the photoreceptor sensory cilium proteome, SDCCAG8 is part of the human centrosomal proteome 22, 23 . The predicted SDCCAG8 protein sequence is highly conserved, including homologs in Ciona intestinalis (sea squirt; XP_002120666.1, 20% identity) and Drosophila melanogaster (NP_732086.1; 16% identity), suggesting that this domain assembly has a conserved function (data not shown). Yeast-two-hybrid interaction analysis has shown that SDCCAG8 forms homodimers 20 .
SDCCAG8 co-localizes with NPHP-RC proteins at centrosomes
Because SDCCAG8 has been described as part of the human centrosomal proteome 20, 23 , and as a defining feature of NPHP-RC proteins is their localization at centrosomes 12, 24 , we evaluated the subcellular localization of SDCCAG8 using immunofluorescence studies in the renal epithelial cell line MDCK-II ( Fig. 2) . For this purpose, we generated antibodies against N-terminal and C-terminal peptides of human SDCCAG8 (Fig. 1e) . Antibodies anti-SDCCAG8-NR, anti-SDCCAG8-NG (raised against N-terminal peptides in rabbit and guinea pig, respectively) and anti-SDCCAG8-CG (raised against C-terminal peptide in guinea pig) recognized upon immunoblotting the endogenous and stably overexpressed full-length isoform a of human and mouse SDCCAG8 (Supplementary Fig. 2a ). The anti-SDCCAG8-NR antibody also recognized isoform a of zebrafish SDCCAG8 (Supplementary Fig. 2b ). Upon coimmunoprecipitation A r t i c l e s of hTERT-RPE lysates with anti-SDCCAG8-PR (Proteintech, rabbit), immunoblotting recognized the SDCCAG8 full-length isoform a (83 kDa) and isoform b (78 kDa) when we used anti-SDCCAG8-PR, anti-SDCCAG8-NR, anti-SDCCAG8-NG or anti-SDCCAG8-CG for immunoblotting. Unlike antibodies anti-SDCCAG8-PR and anti-SDCCAG8-NR, anti-SDCCAG8-CG did not recognize the short isoform e at 41 kDa ( Supplementary Fig. 2c-f ) as the relevant peptide is not part of short isoform e ( Fig. 1e and Supplementary Fig. 2i ).
Immunofluorescence studies confirmed that these antibodies recognize overexpressed SDCCAG8 upon indirect immunofluorescence ( Supplementary Fig. 3a,b ) and that anti-SDCCAG8-PR and anti-SDCCAG8-NG co-localized in the connecting cilia of mouse photoreceptors ( Supplementary Fig. 3c ). Together, these data show that these antibodies are specific for the full-length SDCCAG8 isoform a and that antibodies anti-SDCCAG8-PR and anti-SDCCAG8-NR also recognize the C-terminal short isoform e. We confirmed the presence of SDCCAG8 isoforms a, b and e by RT-PCR in hTERT-RPE cells and direct sequencing (data not shown).
When we evaluated the subcellular localization of SDCCAG8 by immunofluorescence studies in the MDCK-II renal epithelial cell line, we found that SDCCAG8 localizes to centrosomes, but in a location set apart from the γ-tubulin signal that marks centrioles ( Fig. 2a ) and from the signal of CEP164 that marks distal centrosomal appendages 22 (Fig. 2b) . By contrast, there was tight co-localization with ninein, a marker of centrosomal appendages 22 (Fig. 2c) . We found co-localization between SDCCAG8 and both NPHP5 (also called IQCB1) ( Fig. 2d) and OFD1 ( Fig. 2e) , which are disrupted in NPHP-RC. By expressing human SDCCAG8 in mIMCD3 mouse renal epithelial cells, we showed that full-length isoform a is expressed at centrosomes, whereas the N-terminal short isoform e was primarily located in the cytoplasm (Supplementary Fig. 3d ). In addition, SDCCAG8 was localized at cell-cell junctions 25 (Fig. 2a-e ), as has been described for NPHP1 and NPHP4 25 .
Because proteins that are mutated in NPHP-RC localize to the cilia and centrosomes, which become the mitotic spindle pole bodies 24 , we examined the subcellular localization of SDCCAG8 in relation to the cell cycle in MDCK-II cells using γ-tubulin as a centrosomal marker (Supplementary Fig. 4 ) and α-tubulin as a cytoplasmic microtubule marker (Supplementary Fig. 5 ). In cells stably transfected with C-terminally GFP-labeled SDCCAG8, we found that SDCCAG8 localizes to the centrosomes throughout the cell cycle, as shown by its co-localization with γ-tubulin ( Supplementary Fig. 4 ) and α-tubulin ( Supplementary Fig. 5 ). Additionally, in both hTERT-RPE1 (ciliated; Supplementary Fig. 6a,b ) and U2OS osteosarcoma cells (non-ciliated; Supplementary Fig. 6c,d) , SDCCAG8 localizes to each centriole on a centrosome. Similar to what has been described 25 for OFD1, SDCCAG8 is present in all cell cycle phases at the distal part of both centrioles, as shown by its co-localization with centrin, a distal centriolar marker (Supplementary Fig. 6a,c) . The finding that SDCCAG8 is present even in non-ciliated cells and occurs at both centrioles might indicate that it has a more general role in centrosomal function. We conclude that SDCCAG8 is located at the distal ends of both centrioles and that it colocalizes to centrosomes throughout the cell cycle together with other proteins that are disrupted in NPHP-RC.
SDCCAG8 interacts directly with OFD1
To further characterize the protein complex in which SDCCAG8 participates, we performed yeast two-hybrid screening of a human retinal cDNA library, using SDCCAG8 as bait. With both full-length SDCCAG8 and a C-terminal fragment (amino acids 533-713; Fig. 3a,b) , we found that OFD1 interacts directly with SDCCAG8. We found that the C-terminal OFD1 region, which contains the last two out of six predicted coiled-coil motifs (amino acids 615-1,012) bound to the C-terminal region of SDCCAG8 (amino acids 533-713), which also contains two predicted coiled-coil motifs (Fig. 3c) . This interaction was validated by glutathione S-transferase (GST) pulldown experiments (Fig. 3d) and coimmunoprecipitation (Fig. 3e) .
Dominant mutations of OFD1 cause oral-facial-digital syndrome type 1, a male-lethal X-linked dominant condition, and recessive OFD1 mutations cause the NPHP-RC Joubert syndrome and X-linked recessive Simpson-Golabi-Behmel syndrome type 2 (SGBS2) 26 . Whereas dominant mutations in OFD1 abolish its interaction with lebercilin (LCA5) and its pericentriolar localization, recessive mutations only weaken its interaction with lebercilin 26 . To explore the hypothesis that loss of binding to OFD1 as result of mutations in SDCCAG8 underlies the disease mechanism for SLSN in individuals carrying SDCCAG8 mutations, we tested whether the SDCCAG8 mutations p.Cys649fsX658 or p.Glu474fsX493 affect interaction with OFD1. In a liquid β-galactosidase assay, we found that only the SDCCAG8 p.Glu474fsX493 mutation, which affects the OFD1-interacting domain, completely disrupted the interaction, whereas the C-terminal p.Cys649fsX658 mutation caused no difference in binding affinity for OFD1 ( Fig. 3f) . We also assessed the effects on SDCCAG8 binding affinity of six published OFD1 mutations: p.Lys948fs and p.Glu923fs 26 , p.Ile784fs 27 , p.Glu709fs 28 , p.Asn630fs 29 and p.Ser586fs 30 . All dominant OFD1 mutations disrupted binding, and only the p.Glu709fs mutation did not affect affinity for SDCCAG8 ( Fig. 3g) .
SDCCAG8 and NPHP-RC proteins co-localize in photoreceptors
To elucidate the role of SDCCAG8 in the pathogenesis of NPHP-RC, we investigated the expression of SDCCAG8 and other proteins disrupted in NPHP-RC for potential co-localization in mouse retina using indirect immunofluorescence studies (Fig. 4) . We detected a strong signal for SDCCAG8 with antibody anti-SDCCAG8-CG in the transition zone and a weaker signal in inner segments of mouse photoreceptors (Fig. 4a) . This localization was confirmed by high resolution-3D fluorescence imaging after electroporation of two human SDCCAG8 constructs into rat retina (Fig. 4b,c) 
3xFlag-∆N p63 3xHA-SDCCAG8 1-713 (f) Interaction of wild-type (WT) and SDCCAG8 mutants with ODF1 isoform 1 in β-galactosidase assay. Constructs encoding SDCCAG8 as GAL4-BD fusion protein, WT or indicated mutants, were co-transformed with pAD-OFD1 isoform 3 constructs in yeast. Co-transformation of pBD-SDCCAG8 and pAD-MUT vector served as negative control. Remaining LacZ reporter gene activity, corrected for background activity, is indicated. (g) Interaction of WT isoform-3 and OFD1 mutants with SDCCAG8 in yeast two-hybrid assay. Constructs encoding WT SDCCAG8 as GAL4-BD fusion protein were co-transformed in PJ694a with pAD-OFD1 isoform-3 constructs, WT or indicated mutations. Interaction of SDCCAG8 with OFD1 mutant p.Glu709fs and WT was detected as described above. β-galactosidase assays revealed decreased LacZ reporter gene activity for OFD1 all mutations except p.Glu709fs, indicating significantly reduced interaction with SDCCAG8. Error bars represent s.e.m. in f and g. Additional experiments are shown in supplementary Figure 10 .
A r t i c l e s human full-length SDCCAG8 isoform a localized to the transition zone of photoreceptor cells (Fig. 4b) , whereas the short N-terminal isoform e was expressed in the connecting cilia, inner segments and cytoplasm (Fig. 4c) . This confirms the finding in mIMCD3 renal epithelial cells that full-length SDCCAG8 isoform a localizes in the vicinity of centrosomes, whereas the short N-terminal isoform e shows diffuse cytoplasmic expression ( Supplementary Fig. 3d) .
We then examined SDCCAG8 localization in mouse photoreceptors at high resolution. SDCCAG8 was located in the transition zone, distal to the basal body marker γ-tubulin in a contiguous but not overlapping position (Fig. 4d) , and distal to but clearly set apart from the pericentriolar marker CEP290 (Fig. 4e) . This subcellular localization at fine resolution mirrors the findings of centrosomal localization in MDCK-II cell lines, where SDCCAG8 located just distal to the centrosomal marker γ-tubulin ( Fig. 2a) . We tested for co-localization with NPHP5, because NPHP5 is located in the photoreceptor transition zone 6 and shares a similar genotype-phenotype correlation with SDCCAG8 in that homozygous truncating mutations cause the retinal-renal ciliopathy SLSN. As seen in MDCK-II cells (Fig. 2d) , we found tight co-localization of SDCCAG8 with NPHP5 in the transition zone ( Fig. 4f) , compatible with the idea that these proteins share a function in photoreceptors. We obtained a similar result with antibody anti-SDCCAG8-PR (data not shown). Immunogold labeling of antibody anti-SDCCAG8-PR upon ultrathin sectioning of mouse retina confirmed that SDCCAG8 expression was particularly prominent at the distal basal body and the transition zone of mouse photoreceptors (Fig. 4g) . Immunofluorescence studies also showed that SDCCAG8 co-localized with the retinitis pigmentosa proteins RPGRIP and RP1 (Supplementary Fig. 7) .
Sdccag8 knockdown causes developmental defects in zebrafish
Morpholino oligonucleotide-mediated gene knockdown in zebrafish has been successfully used in models of human NPHP-RC, yielding phenotypes of kidney cysts, brain defects and defects in body axis development 2, 7 . To use the zebrafish model, we showed that antibody anti-SDCCAG8-NR cross-reacted against zebrafish SDCCAG8 (Supplementary Fig. 2b) . We tested for sdccag8 knockdown phenotypes using morpholino oligonucleotides against the start codon of A r t i c l e s sdccag8 (AUGMO1) and the splice donor site of exon 6 (SPMO2), both of which efficiently abrogated expression of SDCCAG8 protein (Fig. 5a) . Compared to a standard control morpholino (Fig. 5b) , sdccag8 knockdown using both morpholino oligonucleotides resulted in a developmental phenotype of body axis curvature and shortened and broadened tails ( Fig. 5c-e ). In addition, AUGMO knockdown caused kidney cysts at 72 hours post fertilization (hpf) in 34% (n = 243) of zebrafish compared to the standard morpholino oligonucleotide negative control (3%, n = 158; Fig. 5f-i) . We found hydrocephalus in 36% (n = 128) of knockdown zebrafish (Fig. 5f,j) but only in 7% (n = 158) with standard morpholino oligonucleotide negative control (Fig. 5g,k) .
These findings show that loss of sdccag8 function results in multiple developmental phenotypes that have been described in related NPHP-RC genes, including invs, cep290 and nek8, indicating that mutations in these genes might share disease mechanisms.
Sdccag8 disruption abrogates epithelial lumen formation
The formation of lumen-containing spheroids by renal epithelial cells in 3D culture is an established test for cell polarity defects 31, 32 , which are central to the pathogenesis of NPHP-RC 33 . Knockdown of the proteins NPHP1 and NPHP4 leads to abnormal lumen formation in the 3D culture spheroid assay 25 . To investigate the role of SDCCAG8 in 3D kidney architecture, we transfected mIMCD3 cells with small inhibitory RNA (siRNA) oligonucleotides against murine Sdccag8, random sequences (negative control) or murine Ift88, which causes a severe NPHP-RC phenotype if mutated (positive control) 34 . Using quantitative RT-PCR, we determined that Sdccag8 transcript levels were depleted by 80% and Ift88 was depleted by 89% (data not shown).
Next, we investigated whether Sdccag8 depletion affected 3D spheroid growth in matrigel. After 3 days of culture, cells transfected with control random oligonucleotides formed spheroid structures with a clear lumen, apical cilia, defined tight junctions and clear basolateral structure (Fig. 6a) . Cells transfected with si-Ift88 developed virtually no spheroids or grew as clumps of cells with few cilia evident. Cells transfected with si-Sdccag8 developed spheroids with architectural defects characterized by disturbed localization of β-catenin at the basolateral membrane, fewer tight junctions and an irregular lumen (Fig. 6b) . Abnormal lumina were clearly seen upon si-Sdccag8 knockdown (in 75.8% of spheroids with si-Sdccag8 knockdown versus 19.5% for control siRNA; P = 0.0055) (Fig. 6b) . To exclude the possibility that the effect was due to off-target effects, we stably transfected mIMCD3 cells with full-length human SDCCAG8. These stable lines could still form spheroids with only occasional irregular lumina (16.7%; data not shown). We then repeated the siRNA knockdown of A r t i c l e s the endogenous murine Sdccag8 ortholog and found no significant change in lumen irregularities (16.7%) compared to negative control siRNA (19.5%) (Fig. 6c) . The phenotypic rescue of Sdccag8 knockdown by co-expression of human SDCCAG8 supports the conclusion that lack of SDCCAG8 induces a defect in cell polarity and lumen formation, which may reflect the renal tubular defects found in individuals with a congenital SDCCAG8 mutation (Fig. 6c) .
SDCCAG8 abandons cell-cell junctions in response to cAMP
Increased levels of intracellular cAMP have been strongly associated with the renal cystic phenotype of NPHP-RC 35 . Pharmacological reduction of intracellular cAMP by the vasopressin-2 receptor antagonist tolvaptan or the somatostatin analog octreotide decreased renal cystic disease in mouse models of NPHP-RC, including the mouse model (Pcy) of Nphp3 loss of function 36 . These drugs are currently being tested in phase II trials in humans with polycystic kidney disease 37 . We therefore studied whether the localization of SDCCAG8 at cell-cell junctions ( Fig. 2a-e ) would be altered upon changes in intracellular cAMP.
Increasing doses of the analog 8Br-cAMP caused dose-dependent loss of SDCCAG8 from cell-cell junctions in relation to three controls (peripheral E-cadherin, centrosomal γ-tubulin and centrosomal SDCCAG8; Fig. 6d-g and Supplementary Fig. 8) . We found the same effect when we treated serum-starved cells with forskolin and IBMX, which increase endogenous intracellular cAMP by stimulating adenylyl cyclase and inhibiting phosphodiesterase, respectively, and the effect could be reversed by the adenylyl cyclase inhibitor tolvaptan (Supplementary Fig. 9 ). We conclude that SDCCAG8 translocates away from cell-cell junctions in response to increased intracellular cAMP. Treatment of spheroids with 8Br-cAMP did not result in an effect similar to SDCCAG8 knockdown in spheroids, suggesting that redistribution of SDCCAG8 from the cell periphery in response to 8Br-cAMP and disruption of lumen formation in spheroids might be independent phenomena (data not shown).
DISCUSSION
The discovery of single-gene causes of retinal-renal ciliopathies has generated new insights into the role of the cilia-centrosome-mitotic spindle complex (CCC) for disease mechanisms of dysplasia and degeneration of the kidney, retina, liver, cerebellum and other organs 12 . In addition, it revealed that multiple signaling mechanisms, including Wnt and Sonic hedgehog signaling, are closely connected to ciliary and centrosomal function. However, dozens of essential CCC components within this pathogenesis are still unknown 18 . Their identification has been limited by the fact that additional monogenic causes of ciliopathies are very rare, often occurring only in single families from large international cohorts 9 . This necessitates the ability to identify ciliopathy-causing genes in single families. However, the utility of the emerging techniques of exon capture and massively parallel sequencing is limited by the high number of VRSs that they generate. Here we show the efficiency of an a priori approach to restricting the yield of non-disease-causing variants by combining homozygosity mapping and a candidate gene approach with exon capture and massively parallel sequencing. This approach has the potential to greatly advance disease gene identification in many single-gene disorders, thereby allowing the related pathogenic pathways to be assembled. Particularly in the degenerative variants of NPHP-RC, there is a theoretical time window for prevention or treatment before degeneration of renal and retinal tissue develops in late childhood. However, no treatment is currently available for any of these disorders. In the Pcy mouse model of Nphp3 loss of function, reduction in intracellular cAMP using a vasopressin-2 receptor antagonist resulted in successful delay or even abrogation of renal cystic disease 36 . It will therefore be important to define the role of intracellular cAMP for disease mechanisms of NPHP-RC. In this context, both the spheroid assay and the cell culture assay described here provide useful models for the study of the relationship between intracellular cAMP and the function of genes that are mutated in NPHP-RC. These in vitro models, as well as the zebrafish model of sdccag8 loss of function, lend themselves to high-throughput testing of small molecules that may halt the disease mechanisms of NPHP-RC. Linkage analysis. For genome-wide homozygosity mapping, the GeneChip Human Mapping 250K StyI Array from Affymetrix was used. Non-parametric lod scores were calculated using a modified version of the program GENEHUNTER 2.1 38, 39 through stepwise use of a sliding window with sets of 110 SNPs and the program ALLEGRO 40 to identify regions of homozygosity as described 7,13 using a disease allele frequency of 0.0001 and CEU marker allele frequencies.
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Exon capture array design. We custom designed an exon sequence capture hybridization 385K array (NimbleGen) to capture 13,221 exons of 828 selected ciliopathy candidate genes. Candidate genes were derived from ciliopathy animal models, from the photoreceptor sensory cilia proteome 15 , the human centrosomal proteome 23 and from the cilia proteome database 16 ( Supplementary  Table 3 ). DNA capture resulted in an average 200-fold enrichment of targeted exons. Captured DNA fragment size was reduced by exo-and endonuclease treatment to be suitable for high throughput sequencing on a Solexa/Illumina GA2 platform. To generate random start positions for massively parallel sequencing, ablate NimbleGen linker sequences and reduce fragment sizes, we digested the captured DNA fragments with exonuclease Bal31 (New England Biolabs) and endonuclease DNase I (Roche). DNA (5 μg) was digested with 2 units of Bal31 exonuclease for 5 min at 30 °C in a 200-μl reaction. The reaction was stopped by adding EGTA to a final concentration of 20 mM and immediate heat inactivation at 65 °C for 10 min, followed by Qiaquick PCR column purification (Qiagen). DNA (~2 μg) was further digested by incubating with 1 unit DNAse I (Roche) and freshly prepared reaction buffer (2× reaction buffer contains 20 mM Tris-Cl (pH 7.5), 2 mM CaCl 2 , and 20 mM MnCl 2 ) for 3 min at 16 °C. The reaction was stopped by adding 2 μl EDTA (500 mM) and immediate heat inactivation at 65 °C for 10 min.
Massively parallel sequencing. Library construction (adaptor ligation) of the modified captured fragments was performed using 'Genomic DNA Sample Prep Kit' according to the manufacturer's instructions (Illumina) and fragments separated on a 1.5% agarose gel and excised in the 150-200 bp range. Fragments were purified and subjected to 10 rounds of PCR amplification using complementary linker specific primers. The amount and size distribution of each sample was analyzed on a Bioanalyzer 2100 (Agilent). Single-stranded DNA fragments were annealed to a flow cell surface in a cluster station (Illumina) and 46 cycles of bridge amplification were applied. Fragments were run on a single lane of a Solexa/Illumina Genome Analyzer II platform, generating about 6-14 million single-end sequence reads of 36-39 bases each. Image analysis and base calling was generated by the Genome Analyzer Pipeline 1.5 with default parameters. Illumina specific FASTQ file containing sequence information and quality scores for each base call were exported for further analysis. Sequence evaluation was performed with the CLC Genomics Workbench software. On average, we obtained about 10 million single short reads (5.8-14 million) per lane with 68% of reads on target (range 51-81%). The median sequencing depth per coding nucleotide was 49, with 99% of the targeted exons covered at least fivefold.
Bioinformatics. Genetic location is according to the March 2006 Human
Genome Browser data (see URLs). cDNA cloning. To generate inducible SDCCAG8-EGFP, the SDCCAG8 open reading frame was subcloned by PCR from full length human ESTs (SDCCAG8 human EST Clone ID: 5174799) into the vector pRetroX-Tight-Puro (Clontech). RT-PCR was performed to identify SDCCAG8 isoforms in hTERT-RPE1 cell line. For in vivo photoreceptor localization studies, the wildtype and mutant human SDCCAG8 cDNAs were cloned into a custom-made pCAG-V5-cDNA-IRES-EGFP-pA Gateway destination expression vector using LR clonase II (Invitrogen)-mediated recombination.
Yeast two-hybrid assays. The GAL4-based yeast two-hybrid system (HybriZAP, Stratagene) was used to identify protein-interaction partners of SDCCAG8. The SDCCAG8 full-length and fragments (amino acids 1-294, 286-541, 533-713) fused to a DNA-binding domain (GAL4-BD), were used as baits for screening a human oligo-dT primed retinal cDNA library. The yeast strain PJ69-4A, which carried the HIS3 (histidine), ADE2 (adenine), MEL1 (α-galactosidase) and LacZ (β-galactosidase) reporter genes, was used as a host. Interactions were analyzed by assessment of reporter gene activation via growth on selective media (HIS3 and ADE2 reporter genes), α-galactosidase colorimetric plate assays (MEL1 reporter gene) and β-galactosidase colorimetric filter lift assays (LacZ reporter gene). For analysis of the binding capacities of SDCCAG8 mutant proteins to OFD1, expression constructs encoding SDCCAG8 as a GAL4-BD fusion protein, either wild-type or containing the p.Cys649fsX658 or p.Glu474fsX493 mutation, were cotransformed in PJ694a with a construct pAD-OFD1 isoform-3, encoding OFD1 as a GAL4-AD fusion protein. For analysis of the binding capacities of OFD1 mutant proteins to SDCCAG8, expression constructs encoding amino acids 356-1012 of OFD1 as a GAL4-AD-fusion protein, either wild-type or containing the p.Lys948fs, p.Lys923fs, p.Ile784fs, p.Glu709fs, p.Asn630fs or p.Ser586fs mutation, were cotransformed with a construct encoding the full-length SDCCAG8 fused to GAL4-BD (pBD-SDCCAG8) in PJ69-4a. As a negative control, the empty pAD vector was cotransformed with pBD-SDCCAG8. Detailed protocols for evaluation of the protein interactions are available from the authors.
GST pull-down assay. SDCCAG8 full-length and fragments (amino acids 1-294, 286-541 and 533-713) were cloned into pDEST15 (Gateway cloning system, Invitrogen). For the creation of GST-fusion proteins, BL21-DE3 cells were transformed with pDEST15 constructs. Detailed protocols for GST pull down are available from the authors.
Coimmunoprecipitation. HA-SDCCAG8 (full-length) and 3xFLAG-OFD1 (both splice variants and the fragments encompassing amino acids 356-1012) were co-expressed in HEK293T cells. As a negative control, HA-SDCCAG8 was co-expressed with the functionally unrelated 3xFLAG-dN-p63 protein. After 48 h of expression, cells were lysed on ice in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% Triton X-100) supplemented with complete protease inhibitor cocktail. Lysates were incubated with anti-FLAG M2-agarose from mouse (Sigma-Aldrich) for 5 h at 4 °C. After incubation, beads with bound protein complexes were washed in lysis buffer. Then, beads were taken up in NuPage Sample Buffer and heated for 10 min at 70 °C. Beads were precipitated by centrifugation, and supernatant was run on a NuPAGE Novex 4-12% Bis-Tris SDS-PAGE gel. The interaction of HA-SDCCAG8 with 3xFLAG-OFD1 was assessed by immunoblotting, followed by staining with either monoclonal mouse anti-FLAG or monoclonal mouse anti-HA (Sigma-Aldrich) as a primary antibody and goat anti-mouse RDye800 as a secondary antibody. Fluorescence was analyzed on a Li-Cor Odyssey 2.1 infrared scanner.
Antibodies. The following antibodies were raised: anti-SDCCAG8-NG (raised against human N-terminal peptide PN (Fig. 1e) in guinea pig, amino acids 119-138), anti-SDCCAG8-CG (raised against C-terminal peptide PC (Fig. 1e ) in guinea pig, amino acids 483-502) and anti-SDCCAG8-NR (raised against N-terminal peptide PN (Fig. 1e) in rabbit, amino acids 119-138). Cysteine was added to the N terminus of peptides to facilitate the coupling to maleimide-activated mcKLH (Thermo Fisher Scientific). Rabbits or guinea pigs were then immunized with KLH-coupled peptides (Cocalico Biologicals). To affinity-purify peptide antibodies, appropriate peptides were coupled to Sulfolink resin according to manufacturers recommendation (Thermo Fisher Scientific).The following primary antibodies were used: mouse anti-GFP (Clontech), mouse anti-γ-tubulin (Sigma), mouse anti-acetylatedα-tubulin (Sigma), rabbit anti-γ-tubulin (Sigma), mouse anti-β-actin (BD Biosciences), mouse-anti-glutamylated tubulin (Sigma), mouse anti-centrin (M. Dias), mouse anti-GT335 (C. Janke); rabbit anti-ninein (Biolegend); rabbit anti-SDCCAG8 (Proteintech), rabbit anti-Nphp5 (E. Otto), rabbit anti-OFD1 (E. Nigg), anti-OFD1 (GenTex), rabbit anti-CEP164 (E. Nigg), rabbit
